B03XA01|Erythropoietin/Epoetin beta/|BH049|NEORECORMON|solution for injection, pre-filled syringe|10000|IU|6|60000|Roche Registration GmbH, Германия|502.78|2|1|0|C|8|5| B03XA01|Erythropoietine /human recombinant|BH050|Binocrit|SOL. INJ. PRE-FILLED SYRINGE|10000 IU|IU|6|60000|Sandoz GmbH, Австрия|502.78|2|1|0|C|8|5| B02BX04|ROMIPLOSTIM|BH055|NPLATE|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|250 mcg|mcg|1|250|Amgen Europe B.V., Нидерландия|1206.53|3|1|0|C|1|| B03XA01|Erythropoietine /human recombinant|BH056|Retacrit|SOL. INJ. PRE-FILLED SYRINGE|10000 IU|IU|6|60000|Pfizer Europe MA EEIG, Белгия|502.78|2|1|0|C|8|5| B03XA02|DARBEPOETIN ALFA|BH057|Aranesp|SOLUTION FOR INJECTION PREFILLED SYRINGE WITH NEEDLE GUARD|300 mcg/0,6 ml|mcg/0,6 ml|1|300|Amgen Europe B.V., Нидерландия|866.47|3|1|0|C|8|5| B03XA02|DARBEPOETIN ALFA|BH058|Aranesp|SOLUTION FOR INJECTION PREFILLED SYRINGE WITH NEEDLE GUARD|150 mcg/0,3 ml|mcg/0,3 ml|1|150|Amgen Europe B.V., Нидерландия|433.17|3|1|0|C|8|5| B03XA03|METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA|BH081|MIRCERA|SOL. INJ. PRE-FILLED SYRINGE|150 mcg/0,3 ml|mcg/ 0,3ml|1|150|Roche Registration GmbH, Германия|487.37|3|1|0|C||5| B02BX05|ELTROMBOPAG|BH085|Revolade|TABL. FILM. COAT.|25 mg|mg|28|700|Novartis Europharm Ltd., Ирландия|1882.81|4|0|0|C|3|| B02BX05|ELTROMBOPAG|BH086|Revolade|TABL. FILM. COAT.|50 mg|mg|28|1400|Novartis Europharm Ltd., Ирландия|3765.62|4|0|0|C|3|| B02BB01|HUMAN FIBRINOGEN|BH087|Haemocomplettan P|POWD.FOR SOL. FOR INJ/INF|1 000 mg|mg|1|1000|CSL Behring GmbH, Германия|713.18||||H||| B02BD01|COAGULATION FACTOR IX, II, VII AND X IN COMB.|BH088|OCTAPLEX|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Octapharma (IP) SPRL, Белгия|356.57||||H||| B02BD01|COAGULATION FACTOR IX, II, VII AND X IN COMB.|BH089|Prothromplex Total NF|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|600IU|IU|1|600|Baxalta Innovations GmbH, Австрия|427.88||||H||| B02BD02|COAGULATION FACTOR VIII|BH090|Beriate|POWD. AND SOLV. FOR SOL. FOR INJECTION/INFUSION|1000IU|IU|1|1000|CSL Behring GmbH, Германия|617.42||||H||| B02BD02|COAGULATION FACTOR VIII|BH091|Beriate|POWD. AND SOLV. FOR SOL. FOR INJECTION/INFUSION|250IU|IU|1|250|CSL Behring GmbH, Германия|154.36||||H||| B02BD02|COAGULATION FACTOR VIII|BH092|Beriate|POWD. AND SOLV. FOR SOL. FOR INJECTION/INFUSION|500IU|IU|1|500|CSL Behring GmbH, Германия|308.71||||H||| B02BD02|COAGULATION FACTOR VIII|BH093|Fanhdi|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Instituto Grifols S.A., Испания|308.71||||H||| B02BD02|COAGULATION FACTOR VIII|BH094|Fanhdi|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|250IU|IU|1|250|Instituto Grifols S.A., Испания|154.36||||H||| B02BD02|COAGULATION FACTOR VIII|BH095|Fanhdi|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000IU|IU|1|1000|Instituto Grifols S.A., Испания|617.42||||H||| B02BD02|COAGULATION FACTOR VIII|BH096|Immunate|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Baxalta Innovations GmbH, Австрия|308.71||||H||| B02BD02|COAGULATION FACTOR VIII|BH097|OCTANATE|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Octapharma (IP) SPRL, Белгия|308.71||||H||| B02BD02|COAGULATION FACTOR VIII|BH098|OCTANATE|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000IU|IU|1|1000|Octapharma (IP) SPRL, Белгия|617.42||||H||| B02BD02|COAGULATION FACTOR VIII|BH099|Advate|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Baxter AG, Австрия|613.54||||H||| B02BD02|COAGULATION FACTOR VIII|BH100|Advate 500 IU|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Baxter AG, Австрия|613.54||||H||| B02BD02|COAGULATION FACTOR VIII|BH101|KOGENATE BAYER|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Bayer AG, Германия|613.54||||H||| B02BD02|COAGULATION FACTOR VIII|BH102|KOGENATE BAYER|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Bayer AG, Германия|613.54||||H||| B02BD02|COAGULATION FACTOR VIII|BH103|Kovaltry|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Bayer AG, Германия|613.54||||H||| B02BD02|COAGULATION FACTOR VIII|BH104|NovoEight|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Novo Nordisk A.S., Дания|613.54||||H||| B02BD02|COAGULATION FACTOR VIII|BH105|Nuwiq|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Octapharma AB, Швеция|613.54||||H||| B02BD02|COAGULATION FACTOR VIII|BH106|ReFacto AF|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Pfizer Europe MA EEIG, Белгия|613.54||||H||| B02BD02|COAGULATION FACTOR VIII|BH107|ReFacto AF|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Pfizer Europe MA EEIG, Белгия|613.54||||H||| B02BD02|COAGULATION FACTOR VIII|BH108|Adynovi|POWDER AND SOLVENT FOR INJECTION|500IU|IU|1|500|Baxalta Innovations GmbH, Австрия|762.43||||H||| B02BD02|COAGULATION FACTOR VIII|BH109|Adynovi|POWDER AND SOLVENT FOR INJECTION|1000IU|IU|1|1000|Baxalta Innovations GmbH, Австрия|1524.85||||H||| B02BD02|COAGULATION FACTOR VIII|BH110|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000IU|IU|1|1000|Swedish Orphan Biovitrum AB, Швеция|1524.85||||H||| B02BD02|COAGULATION FACTOR VIII|BH111|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|250IU|IU|1|250|Swedish Orphan Biovitrum AB, Швеция|381.21||||H||| B02BD02|COAGULATION FACTOR VIII|BH112|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Swedish Orphan Biovitrum AB, Швеция|762.43||||H||| B02BD02|COAGULATION FACTOR VIII|BH113|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|3000 IU|IU|1|3000|Swedish Orphan Biovitrum AB, Швеция|4574.56||||H||| B02BD02|COAGULATION FACTOR VIII|BH114|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|2000 IU|IU|1|2000|Swedish Orphan Biovitrum AB, Швеция|3049.71||||H||| B02BD02|COAGULATION FACTOR VIII|BH115|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1500 IU|IU|1|1500|Swedish Orphan Biovitrum AB, Швеция|2287.28||||H||| B02BD03|FACTOR VIII INHIBITOR BYPASSING ACTIVITY|BH116|Feiba|POWDER AND SOLVENT FOR SOLUTION FOR INFUSION|25 U/ml (500 U)|IU|1|500|Baxalta Innovations GmbH, Австрия|762.31||||H||| B02BD04|COAGULATION FACTOR IX|BH118|Aimafix|POWDER AND SOLVENT FOR SOLUTION FOR INFUSION|500IU|IU|1|500|Kedrion S.p.A., Италия|405.7||||H||| B02BD04|COAGULATION FACTOR IX|BH119|IMMUNINE|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION/INFUSION|600IU|IU|1|600|Baxalta Innovations GmbH, Австрия|486.84||||H||| B02BD04|COAGULATION FACTOR IX|BH120|OCTANINE F 500|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Octapharma (IP) SPRL, Белгия|405.7||||H||| B02BD04|COAGULATION FACTOR IX|BH121|Alprolix|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000IU|IU|1|1000|Swedish Orphan Biovitrum AB, Швеция|2257.12||||H||| B02BD04|COAGULATION FACTOR IX|BH122|Alprolix|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|3000 IU|IU|1|3000|Swedish Orphan Biovitrum AB, Швеция|6771.35||||H||| B02BD04|COAGULATION FACTOR IX|BH123|Alprolix|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|2000 IU|IU|1|2000|Swedish Orphan Biovitrum AB, Швеция|4514.24||||H||| B02BD04|COAGULATION FACTOR IX|BH124|Alprolix|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Swedish Orphan Biovitrum AB, Швеция|1128.56||||H||| B02BD04|COAGULATION FACTOR IX|BH125|Alprolix|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|250IU|IU|1|250|Swedish Orphan Biovitrum AB, Швеция|564.28||||H||| B02BD04|COAGULATION FACTOR IX|BH126|BeneFIX|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Pfizer Europe MA EEIG, Белгия|606.37||||H||| B02BD06|VON WILLEBRAND FACTOR AND COAG FACTORVIII IN COMB|BH127|Wilate 500|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Octapharma (IP) SPRL, Белгия|471.14||||H||| B02BD08|EPTACOG ALFA (ACTIVATED)|BH128|NovoSeven|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|2 mg (100 KIU)|KIU|1|100|Novo Nordisk A.S., Дания|2571.35||||H||| B02BD08|EPTACOG ALFA (ACTIVATED)|BH129|NovoSeven|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|5 mg (250 KIU)|KIU|1|250|Novo Nordisk A.S., Дания|6428.38||||H||| H02AB02|Dexamethasone|HH003|Dexamethasone Sopharma|SOLUTION FOR INJECTION|4 mg/ml - 2ml|mg|10|80|Софарма АД, България|7.92|1|0|0|C|2|7| H02AB02|Dexamethasone|HH005|Dexamethasone Sopharma|SOLUTION FOR INJECTION|4 mg/ml - 1 ml|mg|10|40|Софарма АД, България|3.96|1|0|0|C|2|7| H02AB02|Dexamethasone|HH006|Dexamethasone KRKA|SOLUTION FOR INJECTION|4 mg/ml - 1 ml|mg|25|100|KRKA d.d., Словения|9.9|1|0|0|C|2|7| H01CB02|OCTREOTIDE|HH007|Sandostatin LAR|POWD.AND SOLVENT FOR SUSP. INJ.|20 mg|mg|1|20|Novartis Pharma GmbH, Германия|823.23|2|1|0|C|7|2| H01CB02|OCTREOTIDE|HH008|Sandostatin LAR|POWD. FOR SOL. FOR INFUSION|30 mg|mg|1|30|Novartis Pharma GmbH, Германия|1234.99|2|1|0|C|7|2| J06BA02|IMMUNOGLOBULIN HUMAN NORMAL, INTRAVASCULAR|JH001|OCTAGAM 10%|SOL. FOR INF.|100 mg/ml - 20 ml|mg|1|2000|Octapharma (IP) SPRL, Белгия|178.31|1|4|0|C|1|| J06BA02|Normal Human Immunoglobulin (IVI g)|JH002|Privigen|solution for infusion|100 mg/ml - 25 ml|mg|1|2500|CSL Behring GmbH, Гемания|222.89|1|4|0|C|1|| J06BA02|IMMUNOGLOBULIN HUMAN NORMAL, INTRAVASCULAR|JH003|OCTAGAM10%|SOL. FOR INF.|100 mg/ml - 50ml|mg|1|5000|Octapharma (IP) SPRL, Белгия|445.77|1|4|0|C|1|| J06BA02|Normal Human Immunoglobulin (IVI g)|JH004|Privigen|solution for infusion|100 mg/ml - 50 ml|mg|1|5000|CSL Behring GmbH, Гемания|445.77|1|4|0|C|1|| J06BA02|Normal Human Immunoglobulin (IVI g)|JH006|Privigen|solution for infusion|100 mg/ml - 100 ml|mg|1|10000|CSL Behring GmbH, Гемания|891.54|1|4|0|C|1|| J06BA02|IMMUNOGLOBULIN HUMAN NORMAL, INTRAVASCULAR|JH008|Intratect|SOL. FOR INF.|50 G/L - 20 ML|mg|1|1000|Biotest Pharma GmbH, Германия|51.42|1|4|0|C|1|| J06BA02|IMMUNOGLOBULIN HUMAN NORMAL, INTRAVASCULAR|JH011|Intratect|SOL. FOR INF.|50 G/L - 200 ML|mg|1|10000|Biotest Pharma GmbH, Германия|514.2|1|4|0|C|1|| L01DB03|Epirubicin|LH004|Farmorubicin PFS|sol. for inj.|2 mg/ml - 25 ml|mg|1|50|Pfizer Enterprises SARL, Luxembourg|43.33|1|4|0|C||1| L01BC01|Cytarabine|LH005|ALEXAN|solution for injection|50 mg/ ml - 20 ml|mg|1|1000|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|21.44|1|4|0|C||1| L01DB03|Epirubicin|LH015|"EPIRUBICIN ""EBEWE"""|concentrate for solution for injection/ infusion|2 mg/ml- 25 ml|mg|1|50|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|43.33|1|4|0|C||1| L01CD01|Paclitaxel|LH017|Sindaxel|Concentrate for solution for infusion|6 mg/ml - 50 ml|mg|1|300|Актавис ЕАД, България|66.05|1|4|0|C||1| L01DB03|Epirubicin|LH024|EPISINDAN|solution for infusion|2 mg/ml - 50 ml|mg|1|100|Actavis Group PTC ehf, Исландия|86.66|1|4|0|C||1| L01CD01|Paclitaxel|LH030|"Paclitaxel ""Ebewe"""|concentrate for solution for infusion|6 mg/ml - 16,7 ml|mg|1|100.2|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|22.02|1|4|0|C||1| L01CD01|Paclitaxel|LH035|PACLITAXEL KABI|concentrate for solution for infusion|6 mg/ml - 5 ml|mg|1|30|Фрезениус Каби България ЕООД|6.61|1|4|0|C||1| L01CD01|Paclitaxel|LH037|PACLITAXEL KABI|concentrate for solution for infusion|6 mg/ml - 16,7 ml|mg|1|100.2|Фрезениус Каби България ЕООД|22.02|1|4|0|C||1| L01CD01|Paclitaxel|LH043|PACLITAXEL KABI|concentrate for solution for infusion|6 mg/ml - 50 ml|mg|1|300|Фрезениус Каби България ЕООД|66.05|1|4|0|C||1| L01CD01|PACLITAXEL|LH046|Paclitaxel Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|6 mg/ml - 50 ml|mg|1|300|Accord Healthcare Ltd., Обединено Кралство|66.05|1|4|0|C||1| L01DB06|Idarubicin|LH047|ZAVEDOS|powder for sol. for inf.|5 mg|mg|1|5|Pfizer Europe MA EEIG, Белгия|53.88|1|4|0|C||1| L01DB06|Idarubicin|LH065|ZAVEDOS|powder for sol. for inf.|10 mg|mg|1|10|Pfizer Europe MA EEIG, Белгия|107.76|1|4|0|C||1| L01CA04|VINORELBINE|LH073|Vinorelbin Actavis|CONCENTRATE FOR SOLUTION FOR INFUSION|50 mg|mg|1|50|Актавис ЕАД, България|62.39|1|4|0|C|8|1| L01DB07|Mitoxantrone|LH075|MITOXANTRON EBEWE|concentrate for solution for infusion|2 mg/ml - 10 ml|mg|1|20|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|62.51|1|4|0|C|7|1| L01CA04|VINORELBINE|LH078|Vinorelbin Ebewe|CONCENTRATE FOR SOLUTION FOR INFUSION|10 mg/ml - 5 ml|mg|1|50|Ebewe Pharma GmbH. N.fg. KG, Австрия|62.39|1|4|0|C|8|1| L01CB01|ETOPOSIDE|LH083|Etosid|SOL. FOR INF.|20 mg/ml - 5 ml|mg|1|100|Cipla Ltd, UK|12.64|1|4|0|C||1| L01XA01|Cisplatin|LH109|Cisplatin Accord|concentrate for solution for infusion|1 mg/ml - 50 ml|mg|1|50|Accord Healthcare Limited, UK|10.72|1|4|0|C||1| L01XA02|Carboplatin|LH113|CARBOPLATIN EBEWE|Concentrate for solution for infusion|10 mg/ml-15 ml|mg|1|150|Ebewe Pharma GmbH. N.fg. KG,, Австрия|22.39|1|4|0|C||1| L01BB06|Clofarabine|LH117|EVOLTRA|concentrate for sol. for inf.|1 mg/ml - 20 ml|mg|1|20|Genzyme Europe BV, Холандия|2240.84|1|4|0|C||1| L01BB07|NELARABINE|LH119|Atriance|SOL. FOR INF.|5 mg/ml - 50ml|mg|6|1500|Novartis Europharm Ltd., Ирландия|3512.76|1|4|0|C||1| L01BC01|Liposomal Cytarabine|LH121|DepoCyte|suspention for injection|50|mg|1|50|Pacira Ltd, MG House, Rumbolds Hill, Midhurst, West Sussex, GU29 9BY, England|3273.65|1|4|0|C||1| L03AA02|FILGRASTIM|LH123|Nivestim|SOL. FOR INJ/INF IN PRE-FILLED SYRINGE|30 MIU/0.5 ml|mg|5|1.5|Pfizer Europe MA EEIG, Белгия|198.32|3|1|0|C|7|5| L01XA02|Carboplatin|LH127|Carboplatin Actavis|concentrate for solution for infusion|10 mg/ml - 15 ml|mg|1|150|Actavis Group PTC ehf, Исландия|22.39|1|4|0|C||1| L03AA02|Filgrastim|LH128|Zarzio|solution for injection/infusion|30 MU/ 0,5 ml|mg|5|1.5|Sandoz GmbH, Austria|198.32|3|1|0|C|7|5| L01XE07|Lapatinib|LH133|TYVERB|film-coated tablets, bottle|250|mg|84|21000|Novartis Europharm Limited, Ирландия|2375.11|4|0|0|C|3|3| L01XE07|Lapatinib|LH137|TYVERB|film-coated tablets, bottle|250|mg|140|35000|Novartis Europharm Limited, Ирландия|3958.52|4|0|0|C|3|3| L01XE08|Nilotinib|LH139|Tasigna|hard capsules|200|mg|28|5600|Novartis Europharm Limited, Ирландия|1691.7|4|0|0|C|3|3| L01XE08|Nilotinib|LH140|Tasigna|hard capsules|150|mg|28|4200|Novartis Europharm Limited, Ирландия|1268.78|4|0|0|C|3|3| L03AB04|Interferon alfa-2a|LH151|Roferon-A|solution for injection pre-filled syringe + needle|3 MIU|MU|1|3|Рош България ЕООД|23.83|3|1|0|C|8|8| L01XC02|Rituximab|LH154|MabThera|concentrate for sol. for inf.|100|mg/10ml|2|200|Roche Registration GmbH, Германия|594.1|1|4|0|C||3| L01XC02|Rituximab|LH155|MabThera|concentrate for sol. for inf.|500|mg/50ml|1|500|Roche Registration GmbH, Германия|1485.25|1|4|0|C||3| L01XC03|Trastuzumab|LH156|Herceptin|powder for concentrate for solution for infusion|150|mg|1|150|Roche Registration GmbH, Германия|786.5|1|4|0|C||3| L01XE09|Temsirolimus|LH158|TORISEL|Concentrate and diluent for sol. for inf.|30 mg (concentrate: 1.2 ml; diluent: 1.8 )|mg|1|30|Pfizer Europe MA EEIG, Белгия|1637.88|1|4|0|C||3| L01XC06|Cetuximab|LH160|ERBITUX|solution for infusion|5 mg/ml - 20 ml|mg|1|100|Merck KGaA, Германия|385.79|1|4|0|C|7|3| L01XC07|Bevacizumab|LH161|Avastin|concentrate for solution for infusion|25 mg/ml-4 ml|mg|1|100|Roche Registration GmbH, Германия|521.32|1|4|0|C|8|3| L01XE10|EVEROLIMUS|LH162|Afinitor|TABL|5 mg|mg|30|150|Novartis Europharm Ltd., Ирландия|1883.6|4|0|0|C|3|3| L01XC07|Bevacizumab|LH163|Avastin|concentrate for solution for infusion|25 mg/ml-16 ml|mg|1|400|Roche Registration GmbH, Германия|2049.34|1|4|0|C|8|3| L01XE10|EVEROLIMUS|LH164|Afinitor|TABL|10 mg|mg|30|300|Novartis Europharm Ltd., Ирландия|3767.2|4|0|0|C|3|3| L01XC08|Panitumumab|LH165|Vectibix|concentrate for solution for infusion|20mg/ml - 5ml|mg|1|100|Amgen Europe B.V. Холандия|750.41|1|4|0|C|8|3| L01XE11|Pazopanib|LH166|VOTRIENT|film. coated tabl.|200|mg|30|6000|Novartis Europharm Limited, Ирландия|1353.66|4|0|0|C|3|3| L01XE02|Gefitinib|LH167|IRESSA|film. coated tabl.|250|mg|30|7500|AstraZeneca AB, Швеция|3994.45|4|0|0|C|3|3| L01XE03|Erlotinib|LH168|Tarceva|film-coated tabl.|100|mg|30|3000|Roche Registration GmbH, Германия|1290.77|4|0|0|C|3|3| L01XE03|Erlotinib|LH169|Tarceva|film-coated tabl.|150|mg|30|4500|Roche Registration GmbH, Германия|1936.16|4|0|0|C|3|3| L01XE11|Pazopanib|LH170|VOTRIENT|film. coated tabl.|400|mg|60|24000|Novartis Europharm Limited, Ирландия|5414.57|4|0|0|C|3|3| L01XE04|Sunitinib|LH172|Sutent|hard caps.|12.5|mg|30|375|Pfizer Europe MA EEIG, Белгия|2333.43|4|0|0|C|3|3| L01XX17|Topotecan|LH175|Hycamtin|powd. for concentrate for sol. for inf.|4|mg|1|4|Novartis Europharm Limited, Ирландия|74.14|1|4|0|C||1| L01XE04|Sunitinib|LH176|Sutent|hard capsules|25|mg|30|750|Pfizer Europe MA EEIG, Белгия|4666.86|4|0|0|C|3|3| L01XE04|Sunitinib|LH177|Sutent|hard caps.|50|mg|30|1500|Pfizer Europe MA EEIG, Белгия|9333.73|4|0|0|C|3|3| L01XE05|Sorafenib|LH179|Nexavar|film coated tabl.|200|mg|112|22400|Bayer AG, Germany|6604.8|4|0|0|C|3|3| L01XX17|Topotecan|LH180|POTACTASOL|powder for concentrate for solution for infusion|4|mg|1|4|Actavis Group PTC ehf., Исландия|74.14|1|4|0|C||1| L01XE06|Dasatinib|LH181|Sprycel|film-coated tablets|50|mg|60|3000|Bristol-Myers Squibb Pharma EEIG, UK|6729.26|4|0|0|C|3|3| L01XX17|Topotecan|LH184|Hycamtin|caps. hard|1|mg|10|10|Novartis Europharm Limited, Ирландия|558.17|4|0|0|C|3|1| L01BA01|Methotrexate|LH187|METHOTREXATE EBEWE|concentrate for solution for infusion|100 mg/ml - 10 ml|mg|1|1000|Ebewe Pharma Ges.m.b.H. N.fg. KG, Austria|32.99|1|4|0|C||1| L01XX19|Irinotecan|LH196|Irinotecan Actavis|concentrate for solution for injection|20 mg/ml - 5 ml|mg|1|100|Актавис ЕАД, България|29.88|1|3|0|C||1| L01XX23|Mitotane|LH202|Lysodren|tabl.|500|mg|100|50000|Laboratorie HRA Pharma, France|1131.59|4|0|0|C|3|1| L01XE01|Imatinib|LH203|Glivec|film-coated tablets|100|mg|120|12000|Novartis Europharm Limited, Ирландия|202.06|4|0|0|C|3|3| L03AX16|Plerixafor|LH218|Mozobil|solution for injection|20 mg/ml - 1,2 ml|mg|1|24|Genzyme Europe B.V., The Netherlands|11073.67|3|1|0|C||5| L01BB05|Fludarabine phosphate|LH219|Fludarabine Actavis|powder for sol. for inj./inf.|50|mg|1|50|Actavis Group PTC enf., Iceland|118.01|1|4|0|C||1| L01XA03|Oxaliplatin|LH227|Oxaliplatin-Tchaikapharma|powder for solution for infusion|100|mg|1|100|„Чайкафарма Висококачествените Лекарства“ АД”, гр.София|30.44|1|3|0|C||1| L01CD02|Docetaxel|LH229|Docetaxel Accord|concentrate for sol. for inf.|20 mg/1 ml|mg|1|20|Accord Healthcare Ltd, UK|8.31|1|2|0|C||1| L01CD02|Docetaxel|LH230|Docetaxel Accord|concentrate for sol. for inf.|80 mg/4 ml|mg|1|80|Accord Healthcare Ltd, UK|33.24|1|2|0|C||1| L01XX17|Topotecan|LH233|Topotecan Accord|Concentrate for solution for infusion|1 mg/ml - 4 ml|mg|1|4|Accord Healthcare Limited, Обединено Кралство|74.14|1|4|0|C||1| L03AA13|PEGFILGRASTIM|LH234|Neulasta|SOLUTION FOR INJECTION|6 mg|mg|1|6|Amgen Europe B.V., Нидерландия|1064.09|2|1|0|C|7|5| L01XA03|Oxaliplatin|LH237|OXALIPLATIN ACCORD|concentrate for solution for infusion|5 mg/ml - 20 ml|mg|1|100|Аccord Healthcare Limited - Обединено кралство|30.44|1|3|0|C||1| L04AD01|Ciclosporin|LH243|Sandimmun Neoral|caps. soft|25|mg|50|1250|Novartis Pharma GmbH, Germany|32.22|4|0|0|C|3|| L04AD01|Ciclosporin|LH244|Sandimmun Neoral|caps. soft|50|mg|50|2500|Novartis Pharma GmbH, Germany|64.44|4|0|0|C|3|| L04AD01|Ciclosporin|LH253|Sandimmun Neoral|oral solution|100 mg/ml - 50 ml|mg|1|5000|Novartis Pharma GmbH, Germany|136.69|4|0|0|C|3|| L01AX03|TEMOZOLOMIDE|LH256|Temodal|CAPSULE, HARD|100 mg|mg|5|500|Merck Sharp & Dohme Ltd., Обединено Кралство|95.39|4|0|0|C|3|1| L01BC05|GEMCITABINE|LH260|GEMCITABINE ACCORD|CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg/ml - 10 ml|mg|1|1000|Accord Healthcare Ltd., Обединено Кралство|39.1|1|4|0|C|8|1| L01XA03|Oxaliplatin|LH261|Oxaliplatin Actavis|concentrate for solution for infusion|5 mg/ml - 20 ml|mg|1|100|Actavis Group PTC ehf., Iceland|30.44|1|3|0|C||1| L01XE01|Imatinib|LH270|Imakrebin|film-coated tabl.|100|mg|120|12000|Alvogen IPCO, Люксембург|202.06|4|0|0|C|3|3| L01AA09|Bendamustine hydrochloride|LH272|Levact|powder for concentrate for solution for infusion|100 mg|mg|5|500|Astellas Pharma GmbH, Germany|1525.67|1|4|0|C|6|1| L01AX03|Temozolomide|LH273|Blastomat|hard caps.|100|mg|5|500|Alvogen IPCo.SARL Люксембург|95.39|4|0|0|C|3|1| L01CD04|Cabazitaxel|LH274|Jevtana|concentrate and solvent for solution for infusion|60|mg|1|60|Sanofi Aventis Groupe, Франция|7493.05|1|4|0|C||1| L01DB01|Doxorubicin|LH275|Doxorubicin Accord|concentrate for solution for infusion|2 mg/ml-25 ml|mg|1|50|Accord Healthcare Limited Обединено кралство|17.75|1|3|0|C|7|1| L02BX03|Abiraterone acetate|LH277|Zytiga|tabl.|250|mg|120|30000|Janssen-Cilag International NV, Белгия|6459.76|4|0|0|C|3|2| L01XE01|Imatinib|LH278|Glivec|film-coated tabl.|100|mg|120|12000|Novartis Europharm Limited, Ирландия|202.06|4|0|0|C|3|3| L01BC05|GEMCITABINE|LH279|GEMCIT|POWDER FOR SOLUTION FOR INFISION|38 mg/ml 2000 mg, 100 ml|mg|1|2000|Фрезениус Каби България ЕООД|78.2|1|4|0|C|8|1| L01DB01|Doxorubicin hydrochloride|LH281|Myocet|powder, dispersion and concentrate for dispersion for infusion|50|mg|2|100|Teva B.V., Холандия|2062.01|1|2|0|C|7|1| L01XE01|Imatinib|LH285|Imatinib Accord|film-coated tablets|100|mg|120|12000|Accord Healthcare Limited, UK|202.06|4|0|0|C|3|3| L01BC01|CYTARABINE|LH288|Cytarabine Accord|SOL. FOR INJ/INF|100 mg/ml - 10 ml|mg|1|1000|Accord Healthcare Ltd., Обединено Кралство|31.92|1|4|0|C||1| L01BC06|Capecitabine|LH291|Capecitabine Accord|film-coated tabl.|500|mg|120|60000|Accord Healthcare Limited, UK|92.58|4|0|0|C|3|1| L01BC53|tegafur/gimeracil/oteracil|LH302|Teysuno|hard caps.|20 mg/5,8 mg/15,8 mg|mg|84|1680|Nordic Group BV, ,Холандия|631.8|4|0|0|C|3|1| L01XC11|Ipilimumab|LH303|Yervoy|concentrate for solution for infusion|5mg/ml-40 ml|mg|1|200|Bristol-Myers Squibb Pharma EEIG, Великобритания|26540.59|1|4|0|C||4| L01XC11|Ipilimumab|LH304|Yervoy|concentrate for solution for infusion|5 mg/ml-10 ml|mg|1|50|Bristol-Myers Squibb Pharma EEIG, Великобритания|6635.15|1|4|0|C||4| L01XE15|Vemurafenib|LH305|ZELBORAF|film-coated tabl.|240|mg|56|13440|Roche Registration GmbH, Германия|2761.88|4|0|0|C|3|3| L01XX41|Eribulin|LH306|Halaven|solution for injection|0,44 mg/ml - 2 ml|mg|1|0.88|Eisai Europe Limited, UK|726.61|1|4|0|C||1| L01BC02|Fluorouracil|LH309|Fluorouracil Accord|solution for injection or infusion|50 mg/ml - 20 ml|mg|1|1000|Accord Healthcare Limited, UK|5.02|1|4|0|C|8|1| L01XC03|Trastuzumab|LH310|Herceptin|solution for injection|600 mg/5 ml|mg|1|600|Roche Registration GmbH, Германия|3234.52|3|2|0|C|8|3| L01CD01|PACLITAXEL|LH317|Paclitaxel Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|6 mg/ml - 16.7 ml|mg|1|100.2|Accord Healthcare Ltd., Обединено Кралство|22.02|1|4|0|C||1| L01CD02|Docetaxel|LH319|Tolnexa|concentrate for sol. for inf.|20 mg/ml - 4 ml|mg|1|80|KRKA, d. d.|33.24|1|2|0|C||1| L01XC02|Rituximab|LH320|MabThera|sol. for inj.|1400mg/11.7 ml|mg|1|1400|Roche Registration GmbH, Германия|3405.56|3|1|0|C||3| L01XX35|Anagrelide|LH321|THROMBOREDUCTIN|hard caps.|0.5|mg|100|50|AOP Orphan Pharmaceuticals AG, Austria|354.9|4|0|0|C|3|| L01XE01|Imatinib|LH324|Meaxin|film-coated tabl.|100|mg|120|12000|KRKA, d. d.|202.06|4|0|0|C|3|3| L01BC06|Capecitabine|LH326|Ecansya|film-coat. tabl.|500|mg|120|60000|KRKA, d.d.|92.58|4|0|0|C|3|1| L01DB03|Epirubicin hydrochloride|LH332|Episindan|sol. for inj.|2 mg/ml - 25 ml|mg|1|50|Actavis Group PTC ehf|43.33|1|4|0|C||1| L01XC12|Brentuximab vedotin|LH334|Adcetris|powder for concentrate for sol. for inf.|50|mg|1|50|Takeda Pharma A/S, Дания|6685.92|1|2|0|C||3| L01XC13|Pertuzumab|LH335|Perjeta|concentrate for solution for infusion|420|mg|1|420|Roche Registration GmbH, Германия|5547.97|1|2|0|C|8|3| L01XE13|Afatinib|LH336|Giotrif|film-coated tablets|30|mg|28|840|Boehringer Ingelheim International GmbH, Germany|2999.52|4|0|0|C|3|3| L01XE13|Afatinib|LH337|Giotrif|film-coated tablets|40|mg|28|1120|Boehringer Ingelheim International GmbH, Germany|3999.36|4|0|0|C|3|3| L01XE16|Crizotinib|LH338|Xalkori|hard capsules|250|mg|60|15000|Pfizer Europe MA EEIG Белгия|10250.68|4|0|0|C|3|3| L01XE17|Axitinib|LH339|Inlyta|film. coated tabl.|5|mg|56|280|Pfizer Europe MA EEIG, Белгия|7367.58|4|0|0|C|3|3| L01XE18|Ruxolitinib|LH340|Jakavi|tabl.|5|mg|56|280|Novartis Europharm Limited, Ирландия|3493.07|4|0|0|C|3|3| L01XX44|Aflibercept|LH341|Zaltrap|concentrate for sol. for inf.|25 mg/ml - 8 ml|mg|1|200|Sanofi-Aventis Groupe, France|1369.6|1|3|0|C|8|3| L01XX44|Aflibercept|LH342|Zaltrap|concentrate for sol. for inf.|25 mg/ml - 4 ml|mg|1|100|Sanofi-Aventis Groupe, France|684.8|1|3|0|C|8|3| L02BB04|Enzalutamide|LH343|Xtandi|soft capsules|40|mg|112|4480|Astellas Pharma Europe B.V., Нидерландия|6134.6|4|0|0|C|3|2| L03AA14|Lipegfilgrastim|LH344|Lonquex|solution for injection in pre-filled syringe|6mg/0,6ml|mg|1|6|UAB Sicor Biotech, Литва|1231.78|3|1|0|C|7|5| L01AA09|Bendamustine hydrochloride|LH348|Bendamustine Actavis|Powder for concentrate for solution for infusion|2.5mg/ml|mg|1|100|Actavis Group PTC ehf., Исландия|305.13|1|4|0|C|6|1| L01XX32|Bortezomib|LH349|Vortemyel|powder for solution for injection|3.5|mg|1|3.5|Alvogen IPCo S.ar.l, Люксембург|321.05|1|4|0|C||3| L01XX32|Bortezomib|LH354|Bortezomib Actavis|powd. for sol. for inj.|3.5|mg|1|3.5|Actavis Group PTC ehf.|321.05|1|4|0|C||3| L01BC07|Azacitidin|LH355|Vidaza|powd. for susp. for inj.|25mg/ml|mg|1|100|Celgene Europe B.V. Нидерландия|722.36|3|1|0|C||1| L01XC10|Ofatumumab|LH356|Arzerra|concentrate for solution for infusion|100 mg (20 mg/ml), 5 ml|mg|3|300|Novartis Europharm Ltd., UK|1374|1|4|0|C||3| L01XC10|Ofatumumab|LH357|Arzerra|concentrate for solution for infusion|1000 mg (20 mg/ml), 50 ml|mg|1|1000|Novartis Europharm Ltd., UK|4580|1|4|0|C||3| L01XC14|Trastuzumab emtansine|LH358|Kadcyla|powder for concentrate for sol. for inf.|100 mg/5 ml|mg|1|100|Roche Registration GmbH, Германия|3580.64|1|2|0|C||3| L01XC14|Trastuzumab emtansine|LH359|Kadcyla|powder for concentrate for solution for infusion|160 mg/8 ml|mg|1|160|Roche Registration GmbH, Германия|5729.03|1|2|0|C||3| L01XE12|Vandetanib|LH360|Caprelsa|film-coated tabl.|100|mg|30|3000|AstraZeneca AB.|3163.11|4|0|0|C|3|3| L01XE12|Vandetanib|LH361|Caprelsa|film-coated tabl.|300|mg|30|9000|AstraZeneca AB.|9489.36|4|0|0|C|3|3| L01XE14|Bosutinib|LH362|Bosulif|film-coated tabl.|100|mg|28|2800|Pfizer Europe MA EEIG, Белгия|1303.57|4|0|0|C|3|3| L01XE14|Bosutinib|LH363|Bosulif|film-coated tabl.|500|mg|28|14000|Pfizer Europe MA EEIG, Белгия|6517.87|4|0|0|C|3|3| L01XE23|Dabrafenib|LH364|Tafinlar|caps. hard|75|mg|120|9000|Novartis Europharm Limited, Ирландия|12448.63|4|0|0|C|3|3| L01XX43|Vismodegib|LH365|Erivedge|caps. hard|150|mg|28|4200|Roche Registration GmbH, Германия|9737.95|4|0|0|C|3|3| L01AA02|CHLORAMBUCIL|LH366|Leukeran|TABL. FILM. COAT.|2 mg|mg|25|50|Aspen Pharma Trading Ltd., Ирландия|24.83|4|0|0|C|3|1| L01BA04|PEMETREXED|LH367|Pemetrexed Sandoz|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|500 mg|mg|1|500|Sandoz GmbH, Австрия|1063.03|1|2|0|C|7|1| L01BB02|MERCAPTOPURINE|LH368|Puri-Nethol|TABL|50 mg|mg|25|1250|Aspen Pharma Trading Ltd., Ирландия|47.23|4|0|0|C|3|1| L01XC18|РEMBROLIZUMAB|LH369|Keytruda|powd. for concentrate for sol. for inf.|50|mg|1|50|Merck Sharp & Dohme B.V., Нидерландия|3039.42|1|2|0|C||4| L01XC21|Ramucirumab|LH370|Cyramza|concentrate for sol. for inf.|10 mg/ml – 10 ml|mg|2|200|Eli Lilly Nederland B.V.|1607.75|1|3|0|C||3| L01BA04|PEMETREXED|LH372|Pemetrexed Alvogen|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|500 mg|mg|1|500|Alvogen IPCo.S.a.r.l., Люксембург|1063.03|1|2|0|C|7|1| L01BA04|PEMETREXED|LH375|Armisarte|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 20 ml|mg|1|500|Actavis Group PTC ehf., Исландия|1063.03|1|2|0|C|7|1| L01BA04|PEMETREXED|LH376|Armisarte|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 40 ml|mg|1|1000|Actavis Group PTC ehf., Исландия|2126.06|1|2|0|C|7|1| L01XE01|Imatinib|LH377|Imatinib Actavis Group|film-coated tabl.|100|mg|120|12000|Actavis Group PTC ehf., Исландия|202.06|4|0|0|C|3|3| L01AX03|TEMOZOLOMIDE|LH379|Temozolomide Accord|CAPSULE, HARD|100 mg|mg|5|500|Accord Healthcare Ltd., Обединено Кралство|95.39|4|0|0|C|3|1| L01XX32|Bortezomib|LH380|Bortezomib Accord|Powder for solution for injection|3.5|mg|1|3.5|Accord Healthcare Limited, UK|321.05|1|4|0|C||3| L01BC02|FLUOROURACIL|LH382|5-Fluorouracil Ebewe|CONCENTRATE FOR SOL. FOR INJECTION/INFUSION|50 mg/ml - 20 ml||10|10000|Ebewe Pharma GmbH. N.fg. KG, Австрия|50.2|1|4|0|C|8|1| L01CD02|Docetaxel|LH383|DOCETAXEL ACTAVIS|Concentrate for sol. for inf.|20 mg/ml- 8 ml|mg|1|160|Actavis Group PTC ehf., Исландия|66.47|1|2|0|C||1| L01BA04|Pemetrexed|LH384|Pemetrexed Heaton|powder for concentrate for solution for infusion|500|mg|1|500|Heaton k.s., Чешка република|1063.03|1|2|0|C|7|1| L03AX03|Mycobacterium bovis BCG|LH386|CALGEVAX|Powder for suspension|11.25|mg|4|45|БУЛ БИО-НЦЗПБ ЕООД, България|149.76|1|4|0|C|6|4| L01BA04|PEMETREXED|LH387|Pemetrexed Accord|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|500 mg|mg|1|500|Accord Healthcare Ltd., Обединено Кралство|1063.03|1|2|0|C|7|1| L01BC05|Gemcitabine|LH388|Gemcitabine Actavis|Concentrate for solution for infusion|40 mg/ml – 25 ml|mg|1|1000|Actavis Group PTC ehf., Исландия|39.1|1|4|0|C|8|1| L01BC05|Gemcitabine|LH389|Gemcitabine Actavis|Concentrate for solution for infusion|40 mg/ml – 50 ml|mg|1|2000|Actavis Group PTC ehf., Исландия|78.2|1|4|0|C|8|1| L01XE27|Ibrutinib|LH390|Imbruvica|Capsule, hard|140|mg|90|12600|Janssen-Cilag International N.V., Белгия|12132.49|4|0|0|C|3|3| L01XX46|Olaparib|LH391|Lynparza|Capsule, hard|50|mg|448|22400|Astra Zeneca AB, Швеция|10308.77|4|0|0|C|3|3| L01XE17|Axitinib|LH393|Inlyta|film coated tabl.|1|mg|56|56|Pfizer Europe MA EEIG, Белгия|1473.52|4|0|0|C|3|3| L01XE03|Erlotinib|LH394|Varlota|Film coated tablet|100|mg|30|3000|Alvogen Malta Operations (ROW) Ltd., Малта|1290.77|4|0|0|C|3|3| L01XE03|Erlotinib|LH395|Varlota|Film coated tablet|150|mg|30|4500|Alvogen Malta Operations (ROW) Ltd., Малта|1936.16|4|0|0|C|3|3| L01XC18|Рembrolizumab|LH399|Keytruda|Concentrate for solution for infusion|25 mg/ml - 4 ml|mg|1|100|Merck Sharp & Dohme B.V., Нидерландия|6078.84|1|2|0|C||4| L01XE01|Imatinib|LH401|Imatinib Teva Pharma|Film coated tablet|100|mg|120|12000|Teva B.V., Нидерландия|202.06|4|0|0|C|3|3| L01XE01|Imatinib|LH402|Imatinib Teva Pharma|Film coated tablet|100|mg|120|12000|Teva B.V., Нидерландия|202.06|4|0|0|C|3|3| L01XE01|Imatinib|LH403|Nibix|Capsule, hard|100|mg|120|12000|Adamed Sp.z.o.o., Полша|202.06|4|0|0|C|3|3| L01XE03|Erlotinib|LH404|Erlotinib Sandoz|Film coated tablet|100|mg|30|3000|Sandoz d.d., Словения|1290.77|4|0|0|C|3|3| L01XE03|Erlotinib|LH405|Erlotinib Actavis|Film coated tablet|100|mg|30|3000|Actavis Group PTC ehf., Исландия|1290.77|4|0|0|C|3|3| L01XE03|Erlotinib|LH406|Erlotinib Actavis|Film coated tablet|150|mg|30|4500|Actavis Group PTC ehf., Исландия|1936.16|4|0|0|C|3|3| L01DB11|Pixantrone|LH408|Pixuvri|Powder for concentrate for solution for infusion|29|mg|1|29|CTI Life Sciences Limited, Обединено Кралство|988.12|1|4|0|C||1| L01XC15|Obinutuzumab|LH409|Gazyvaro|Concentrate for solution for infusion|1000 mg - 40 ml|mg|1|1000|Roche Registration GmbH, Германия|7299|1|4|0|C||3| L01XC17|Nivolumab|LH410|Opdivo|Concentrate for solution for infusion|10 mg/ml - 10 ml|mg|1|100|Bristol-Myers Squibb Pharma EEIG, Обединено Кралство|2443.25|1|2|0|C||4| L01XC17|Nivolumab|LH411|Opdivo|Concentrate for solution for infusion|10 mg/ml - 4 ml|mg|1|40|Bristol-Myers Squibb Pharma EEIG, Обединено Кралство|977.3|1|2|0|C||4| L01XC19|blinatumomab|LH412|Blincyto|powder for concentrate and solution for solution for infusion|38.5|mcg|1|38.5|Amgen Eurоpe B.V., Нидерландия|5318.82|1|2|0|C||3| L01XC27|olaratumab|LH413|Lartruvo|Concentrate for solution for infusion|10 mg/ml - 19 ml|mg|2|380|Eli Lilly Nederland B.V, Нидерландия|2276.81|1|4|0|C||3| L01XE21|Regorafenib|LH414|Stivarga|Film coated tablet|40|mg|84|3360|Bayer AG, Германия|5114.14|4|0|0|C|3|3| L01XE24|Ponatinib|LH415|Iclusig|Film coated tablet|15|mg|60|900|Incyte Biosciences Distribution B.V., Нидерландия|12613.02|4|0|0|C|3|3| L01XE33|palbociclib|LH416|Ibrance|Capsule, hard|75|mg|21|1575|Pfizer Europe MA EEIG, Белгия|4515.57|4|0|0|C|3|3| L01XE33|palbociclib|LH417|Ibrance|Capsule, hard|100|mg|21|2100|Pfizer Europe MA EEIG, Белгия|6020.76|4|0|0|C|3|3| L01XE33|palbociclib|LH418|Ibrance|Capsule, hard|125|mg|21|2625|Pfizer Europe MA EEIG, Белгия|7525.96|4|0|0|C|3|3| L01XE35|Osimertinib|LH419|Tagrisso|Film coated tablet|40|mg|28|1120|Astra Zeneca AB, Швеция|7105.74|4|0|0|C|3|3| L01XE35|Osimertinib|LH420|Tagrisso|Film coated tablet|80|mg|28|2240|Astra Zeneca AB, Швеция|14211.47|4|0|0|C|3|3| L01XX45|Carfilzomib|LH421|Kyprolis|Powder for solution for infusion|60|mg|1|60|Amgen Eurоpe B.V., Нидерландия|2227.56|1|4|0|C||3| L01XX52|venetoclax|LH422|Venclyxto|Film coated tablet|50|mg|7|350|AbbVie Deutschland GmbH & Co. KG, Германия|385.43|4|0|0|C|3|3| L01XX52|venetoclax|LH423|Venclyxto|Film coated tablet|100|mg|7|700|AbbVie Deutschland GmbH & Co. KG, Германия|770.86|4|0|0|C|3|3| L01XX52|venetoclax|LH424|Venclyxto|Film coated tablet|100|mg|14|1400|AbbVie Deutschland GmbH & Co. KG, Германия|1541.72|4|0|0|C|3|3| L01XX52|venetoclax|LH425|Venclyxto|Film coated tablet|10|mg|14|140|AbbVie Deutschland GmbH & Co. KG, Германия|154.17|4|0|0|C|3|3| L01XX52|venetoclax|LH426|Venclyxto|Film coated tablet|100|mg|112|11200|AbbVie Deutschland GmbH & Co. KG, Германия|12333.73|4|0|0|C|3|3| L01XE03|Erlotinib|LH427|Erlotinib Sandoz|Film coated tablet|150|mg|30|4500|Sandoz d.d., Словения|1936.16|4|0|0|C|3|3| L01AA01|Cyclophosphamide|LH430|Endoxan|Powder for solution for injection|500|mg|1|500|Екофарм Груп АД, България|26.36|1|4|0|C|7|1| L01XX32|Bortezomib|LH431|Bortega|Powder for solution for injection|3.5|mg|1|3.5|Heaton k.s., Чешка република|321.05|1|4|0|C||3| L01XX32|Bortezomib|LH432|Bortezocon|Powder for solution for injection|3.5|mg|1|3.5|Фармаконс АД, България|321.05|1|4|0|C||3| L01AA06|Ifosfamide|LH433|Holoxan|Powder for solution for infusion|2000|mg|1|2000|Екофарм Груп АД, България|188.84|1|4|0|C||1| L01CD02|Docetaxel|LH434|Docetaxel AqVida|Concentrate for solution for infusion|20 mg/ml-4ml|mg|1|80|AqVida GmbH, Германия|33.24|1|2|0|C||1| L01XA03|Oxaliplatin|LH435|Oxaliplatin Bulgermed VE|Concentrate for solution for infusion|5 mg/ml - 20 ml|mg|1|100|Булгермед ВЕ ООД, България|30.44|1|3|0|C||1| L01XC02|Rituximab|LH436|Truxima|Concentrate for solution for infusion|100|mg|2|200|Celltrion Healthcare Hungary Kft., Унгария|594.1|1|4|0|C||3| L01XC02|Rituximab|LH437|Truxima|Concentrate for solution for infusion|500|mg|1|500|Celltrion Healthcare Hungary Kft., Унгария|1485.25|1|4|0|C||3| L01AA09|Bendamustine|LH438|Bendamustine Mylan|Powder for concentrate for solution for infusion|2.5 mg/ml - 50 ml (100 mg)|mg|5|500|Mylan S.A.S., Франция|1525.67|1|4|0|C|6|1| L01BB06|CLOFARABINE|LH439|Clofarabin Alvogen|CONCENTRATE FOR SOLUTION FOR INFUSION|1mg/ml - 20ml|mg|1|20|Alvogen Malta Operations (ROW) Ltd., Малта|2240.84|1|4|0|C||1| L01AA09|Bendamustine|LH440|Bendamustine Accord|Powder for concentrate for solution for infusion|2.5 mg/ ml - 50 ml (100 mg)|mg|5|500|Accord Healthcare Limited, Обединено Кралство|1525.67|1|4|0|C|6|1| L01BB05|Fludarabine|LH441|Fludarabine Accord|Concentrate for solution for injection/infusion|25 mg/ml - 2 ml|mg|10|500|Accord Healthcare Limited, Обединено Кралство|1180.08|1|4|0|C||1| L03AA02|Filgrastim|LH442|Accofil|Solution for injection/infusion|30 MU (300 mcg/0.5 ml)|mg|5|1.5|Accord Healthcare Limited, Обединено Кралство|198.32|3|1|0|C|7|5| L01BA01|Methotrexate|LH443|Methotrexate Accord|Concentrate for solution for infusion|100 mg/ml - 10 ml|mg|1|1000|Accord Healthcare Limited, Обединено Кралство|32.99|1|4|0|C||1| L01XC03|Trastuzumab|LH444|Kanjinti|Powder for concentrate for solution for infusion|150|mg|1|150|Amgen Eurоpe B.V., Нидерландия|786.5|1|4|0|C||3| L01XC03|Trastuzumab|LH445|Kanjinti|Powder for concentrate for solution for infusion|420|mg|1|420|Amgen Eurоpe B.V., Нидерландия|2202.2|1|4|0|C||3| L01XX19|Irinotecan|LH446|Irinotecan Accord|Concentrate for solution for infusion|20 mg/ml-5 ml|mg|1|100|Accord Healthcare Limited, Обединено Кралство|29.88|1|3|0|C||1| L01XE03|Erlotinib|LH448|Erlotinib Heaton|Film coated tablet|100|mg|30|3000|Heaton k.s., Чешка република|1290.77|4|0|0|C|3|3| L01XE03|Erlotinib|LH449|Erlotinib Heaton|Film coated tablet|150|mg|30|4500|Heaton k.s., Чешка република|1936.16|4|0|0|C|3|3| L01CB01|ETOPOSIDE|LH450|Etoposide Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 5 ml|mg|1|100|Accord Healthcare Ltd., Обединено Кралство|12.64|1|4|0|C||1| L01XC03|Trastuzumab|LH451|Herzuma|Powder for concentrate for solution for infusion|150|mg|1|150|Celltrion Healthcare Hungary Kft., Унгария|786.5|1|4|0|C||3| L01XE10|EVEROLIMUS|LH452|Everolimus Krka|TABL|5 mg|mg|30|150|KRKA d.d., Словения|1883.6|4|0|0|C|3|3| L01XE10|EVEROLIMUS|LH453|Everolimus Krka|TABL|10 mg|mg|30|300|KRKA d.d., Словения|3767.2|4|0|0|C|3|3| L01XC02|Rituximab|LH454|Rixathon|Concentrate for solution for infusion|100 mg/10 ml|mg|2|200|Sandoz GmbH, Австрия|594.1|1|4|0|C||3| L01XC02|Rituximab|LH455|Rixathon|Concentrate for solution for infusion|500 mg/50 ml|mg|1|500|Sandoz GmbH, Австрия|1485.25|1|4|0|C||3| L01CD01|PACLITAXEL|LH456|Paclitaxel Bulgermed|CONCENTRATE FOR SOLUTION FOR INFUSION|6 mg/ml - 50 ml|mg|1|300|Булгермед ВЕ ООД, България|66.05|1|4|0|C||1| L01XX32|Bortezomib|LH457|Bortezomib Sandoz|Powder for solution for injection|3.5|mg|1|3.5|Sandoz d.d., Словения|321.05|1|4|0|C||3| L01XC02|Rituximab|LH458|MabThera|Solution for injection|1600 mg/13.4 ml|mg|1|1600|Roche Registration GmbH, Германия|3892.06|3|1|0|C||3| L01BC59|TRIFLURIDINE/TIPIRACIL|LH459|Lonsurf|TABL. FILM. COAT.|15mg/6.14mg|MG|20|300|Les Laboratoires Servier, Франция|1165.76|4|0|0|C|3|1| L01CD02|DOCETAXEL|LH460|Docetaxel Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|160 mg/ 8 ml|mg|1|160|Accord Healthcare Ltd., Обединено Кралство|66.47|1|2|0|C||1| L01BC59|TRIFLURIDINE/TIPIRACIL|LH461|Lonsurf|TABL. FILM. COAT.|20mg/8.19mg|MG|20|400|Les Laboratoires Servier, Франция|1553.02|4|0|0|C|3|1| L01XA03|OXALIPLATIN|LH463|Oxaliplatin Bulgermed VE|CONCENTRATE FOR SOLUTION FOR INFUSION|5 MG/ML - 40 ML|mg|1|200|Булгермед ВЕ ООД, България|60.88|1|3|0|C||1| L01XC24|DARATUMUMAB|LH464|DARZALEX|CONCENTRATE FOR SOLUTION FOR INFUSION|20 MG/ ML - 20ML|mg|1|400|Janssen-Cilag International N.V., Белгия|3964.34|1|4|0|C||4| L01XE36|ALECTINIB|LH465|Alecensa|CAPSULE, HARD|150 mg|mg|224|33600|Roche Registration GmbH, Германия|10270.25|4|0|0|C|3|1| L01XX50|IXAZOMIB|LH466|Ninlaro|CAPSULE, HARD|2.3 mg|mg|3|6.9|Takeda Pharma A/S, Дания|5236.3|4|0|0|C|3|1| L01XX50|IXAZOMIB|LH467|Ninlaro|CAPSULE, HARD|3 mg|mg|3|9|Takeda Pharma A/S, Дания|6829.96|4|0|0|C|3|1| L01XX50|IXAZOMIB|LH468|Ninlaro|CAPSULE, HARD|4 mg|mg|3|12|Takeda Pharma A/S, Дания|9106.61|4|0|0|C|3|1| L01XC26|INOTUZUMAB OZOGAMICIN|LH469|BESPONSA|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|1 mg|mg|1|1|Pfizer Europe MA EEIG, Белгия|22375.02|1|4|0|C||4| L01XC32|ATEZOLIZUMAB|LH470|Tecentriq|CONCENTRATE FOR SOLUTION FOR INFUSION|1200 mg - 20 ml|mg|1|1200|Roche Registration GmbH, Германия|8886.65|1|2|0|C||4| L01XE10|EVEROLIMUS|LH471|Everolimus Mylan|TABL|5 mg||30|150|Mylan Iraland Limited, Ирландия|1883.6|4|0|0|C|3|3| L01XE10|EVEROLIMUS|LH472|Everolimus Mylan|TABL|10 mg||30|300|Mylan Iraland Limited, Ирландия|3767.2|4|0|0|C|3|3| L01XE10|EVEROLIMUS|LH473|Everolimus Teva|TABL|10 mg|mg|30|300|Teva B.V, Нидерландия|3767.2|4|0|0|C|3|3| L01XC03|TRASTUZUMAB|LH474|Trazimera|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|150 mg|MG|1|150|Pfizer Enterprises S.A.R.L., Люксембург|786.5|1|4|0|C||3| L01XE01|IMATINIB|LH475|Meaxin|TABL. FILM. COAT.|100 mg|mg|120|12000|KRKA d.d., Словения|202.06|4|0|0|C|3|3| L03AA13|PEGFILGRASTIM|LH476|Pelgraz|SOLUTION FOR INJECTION|10mg/ml-0.6 ml|mg|1|6|Accord Healthcare Ltd., Обединено Кралство|1064.09|2|1|0|C|7|5| L03AA13|PEGFILGRASTIM|LH477|Ziextenzo|SOLUTION FOR INJECTION|10mg/ml-0.6 ml|mg|1|6|Sandoz GmbH, Австрия|1064.09|2|1|0|C|7|5| L01XC03|TRASTUZUMAB|LH478|Ogivri|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|150 mg|MG|1|150|Mylan S.A.S., Франция|786.5|1|4|0|C||3| M05BA06|Ibandronic acid|MH004|IBANDRONIC ACID SANDOZ|cincentrate for solution for infusion|6 mg/6 ml|mg|5|30|Sandoz d.d., Slovenia|662.15|1|4|0|C|8|6| M05BA08|Zoledronic acid|MH012|Zoledronic acid Actavis|concentrate for solution for infusion|4mg/5ml|mg|1|4|Actavis Group PTC enf., Исландия|22.91|1|4|0|C||6| M05BA06|Ibandronic acid|MH014|Ibandronic acid Accord|Concentrate for solution for infusion|6 mg/6 ml|mg|1|6|Accord Healthcare Limited, Обединено Кралство|132.43|1|4|0|C|8|6| M05BA08|Zoledronic acid|MH015|Zoledronic acid Fresenius Kabi|concentrate for solution for infusion|4mg/5ml|mg|1|4|Фрезениус Каби България ЕООД|22.91|1|4|0|C||6| M05BX04|Denosumab|MH017|Xgeva|sol. for inj.|120 mg/1.7ml|mg|1|120|Amgen Europe BV., The Netherlands|568.8|3|1|0|C|8|6| M05BA08|Zoledronic acid|MH022|Zoledronic acid Accord|concentrate for sol. for inf.|4 mg/5 ml|mg|1|4|Accord Healthcare Ltd, UK|22.91|1|4|0|C||6| N02AA01|Morphine|NO572|MORPHINE SOPHARMA sol. inj. 20 mg/ml - 1 ml x 100|sol. inj.|20mg/ml-1ml|mg|100|2000|Софарма АД, Илиенско шосе 16, 1220 София, България|144.77|2|0|1|C||| N02AA05|Oxycodone|NO580|OXYCONTIN|modified-release tabl.|20|mg|50|1000|Mundipharma Ges.m.b.H, Austria|16.98|4|0|1|C||| N02AA05|Oxycodone|NO581|OXYCONTIN|modified-release tabl.|80|mg|50|4000|Mundipharma Ges.m.b.H, Austria|67.93|4|0|1|C||| N02AA05|Oxycodone|NO582|OXYCONTIN|modified-release tabl.|10|mg|50|500|Mundipharma Ges.m.b.H, Austria|8.5|4|0|1|C||| N02AA05|Oxycodone|NO583|OXYCONTIN|modified-release tabl.|40|mg|50|2000|Mundipharma Ges.m.b.H, Austria|33.97|4|0|1|C||| N02AA55|Oxycodone hidrochloride/ Naloxone hidrochloride|NO584|TARGIN|prolonged release tablets|5mg/2.5 mg|mg|50|250|Mundipharma GmbH, Австрия|17.7|4|0|1|C||| N02AA55|Oxycodone hidrochloride/ Naloxone hidrochloride|NO585|TARGIN|prolonged release tablets|10mg/5mg|mg|50|500|Mundipharma GmbH, Австрия|35.46|4|0|1|C||| N02AA55|Oxycodone hidrochloride/ Naloxone hidrochloride|NO586|TARGIN|prolonged release tablets|20mg/10 mg|mg|50|1000|Mundipharma GmbH, Австрия|70.87|4|0|1|C||| N02AB02|Pethidine hydrochloride|NO588|LYDOL sol.for inj. 50 mg/ml- 2 ml x 10|solution for injection|50mg/ml-2ml|mg|10|1000|Софарма АД, Илиенско шосе 16, 1220 София, България|16.8|2|0|1|C||| N02AB02|Pethidine hydrochloride|NO589|LYDOL sol.for inj. 50 mg/ml- 2 ml x 50|solution for injection|50mg/ml-2 ml|mg|50|5000|Софарма АД, Илиенско шосе 16, 1220 София, България|84|2|0|1|C||| N02AB03|Fentanyl|NO590|Victanyl 75 micrograms/h transdermal patches x 5|transdermal patches|75 mcg/h|mcg|5|375|Actavis Group PTC ehf, Iceland|40.24|4|0|1|C||| N02AB03|Fentanyl|NO592|Victanyl 50 micrograms/h transdermal patches x 5|transdermal patches|50 mcg/h|mcg|5|250|Actavis Group PTC ehf, Iceland|26.83|4|0|1|C||| N02AB03|Fentanyl|NO593|Victanyl 100 micrograms/h transdermal patches x 5|transdermal patches|100 mcg/h|mcg|5|500|Actavis Group PTC ehf, Iceland|53.65|4|0|1|C||| N02AA01|Morphine|NO597|MORPHINE SOPHARMA sol. inj. 20 mg/ml - 1 ml x 10|sol. inj.|20mg/ml-1ml|mg|10|200|Софарма АД, Илиенско шосе 16, 1220 София, България|14.48|2|0|1|C||| N02AA05|Oxycodone|NO600|Oxycodone Actavis|caps. hard|10|mg|50|500|Actavis Group PTC ehf, Iceland|8.5|4|0|1|C||| N02AA05|Oxycodone|NO601|Oxycodone Actavis|caps. hard|20|mg|50|1000|Actavis Group PTC ehf, Iceland|16.98|4|0|1|C||| N02AA55|Oxycodone hidrochloride/ Naloxone hidrochloride|NO603|TARGIN|prolong. release tabl.|40mg/20mg| mg|100|4000|Mundipharma GmbH, Австрия|283.52|4|0|1|C||| N02AE01|Buprenorphine|NO604|Buprenorphin Actavis|transdermal patch|35 mcg/h|mcg|5|175|Actavis Group PTC ehf, Iceland|25.27|4|0|1|C||| N02AE01|Buprenorphine|NO605|Buprenorphin Actavis|transdermal patch|52,5 mcg/h|mcg|5|261|Actavis Group PTC ehf, Iceland|37.9|4|0|1|C||| N02AE01|Buprenorphine|NO606|Buprenorphin Actavis|transdermal patch|70 mcg/h|mcg|5|350|Actavis Group PTC ehf, Iceland|50.53|4|0|1|C||| N02AA01|Morphine|NO610|Doltard|prolong release tabl.|30|mg|100|3000|Takeda Pharma A/S, Denmark|21.37|4|0|1|C||| N02AX02|Tramadol|NO611|TRAMADOL STADA|sol. for inj.| 50 mg/ml - 2 ml|mg|5|500|Stada Arzenimittel AG|4.88|2|0|1|C||| N02AA05|Oxycodone hydrochloride|NO612|Oxycodone Actavis|prolonged-release tabl.|10|mg|50|500|Actavis Group PTC ehf., Исландия|8.5|4|0|1|C||| N02AA05|Oxycodone hydrochloride|NO613|Oxycodone Actavis|prolonged-release tabl.|20|mg|50|1000|Actavis Group PTC ehf., Исландия|16.98|4|0|1|C||| N02AA05|Oxycodone hydrochloride|NO614|Oxycodone Actavis|prolonged-release tabl.|40|mg|50|2000|Actavis Group PTC ehf., Исландия|33.97|4|0|1|C||| N02AA05|Oxycodone hydrochloride|NO615|Oxylan|prolonged- release tabl.|5|mg|50|250|G.L.Pharma GmbH., Австрия|4.24|4|0|1|C||| N02AA05|Oxycodone|NO616|Oxylan|prolong release tabl.|10|mg|50|500|G. L. Pharma GmbH, Austria|8.5|4|0|1|C||| N02AA05|Oxycodone hydrochloride|NO617|Oxylan|prolonged- release tablets|20|mg|50|1000|G.L.Pharma GmbH., Австрия|16.98|4|0|1|C||| N02AA05|Oxycodone hydrochloride|NO618|Oxylan|prolonged- release tablets|40|mg|50|2000|G.L.Pharma GmbH., Австрия|33.97|4|0|1|C||| N02AA05|Oxycodone hydrochloride|NO619|Oxylan|prolonged- release tablets|80|mg|50|4000|G.L.Pharma GmbH., Австрия|67.93|4|0|1|C||| N02AX52|Tramadol/Paracetamol|NO620|Paratramol|film-coated tabl.|37,5mg/325mg|mg|10|3625|Pharmaceutical Works POLPHARMA S.A.|1.92|4|0|1|C||| N02AB03|Fentanyl|NO621|Vellofent|Sublingual tablet|133 mcg|mcg|4|532|Анджелини Фарма България ЕООД, България|51.55|4|0|1|C||| N02AA05|Oxycodone, Naloxone|NO622|Adolax|Prolonged release tablet|20 mg/ 10 mg|mg|60|1200|KRKA, d.d., Словения|85.06|4|0|1|C||| N02AA05|Oxycodone, Naloxone|NO623|Adolax|Prolonged release tablet|10 mg/ 5 mg|mg|60|600|KRKA, d.d., Словения|42.53|4|0|1|C||| N02AA05|Oxycodone, Naloxone|NO624|Adolax|Prolonged release tablet|40 mg/ 20 mg|mg|60|2400|KRKA, d.d., Словения|170.12|4|0|1|C||| N02AX52|Tramadol, Paracetamol|NO625|Doreta|Film coated tablet|37.5 mg/325 mg|mg|60|21750|KRKA, d.d., Словения|11.53|4|0|1|C||| N02AX52|Tramadol, Paracetamol|NO626|Doreta|Film coated tablet|75 mg/650 mg|mg|60|43500|KRKA, d.d., Словения|21.05|4|0|1|C||| N02AA55|OXYCODONE HYDROCHLORIDE/ NALOXONE HYDROCHLORIDE|NO627|Oxycodone/Naloxone Teva|TABL. RELEASE PROLONG|10mg/5mg|mg|50|500|Teva B.V, Нидерландия|35.46|4|0|1|C||| N02AA55|OXYCODONE HYDROCHLORIDE/ NALOXONE HYDROCHLORIDE|NO628|Oxycodone/Naloxone Teva|TABL. RELEASE PROLONG|20mg/10mg|mg|50|1000|Teva B.V, Нидерландия|70.87|4|0|1|C||| N02AA08|Dihydrocodeine|NP414|DHC Continus|modified-release tablets|90|mg|50|4500|Mundipharma Ges.m.b.H., Vienna, Austria|37.45|4|0|1|C||| N02AX02|Tramadol|NP415|TRAMALGIN sol.for inj. 50 mg/ml-2 ml x10|sol.for inj.|50 mg/ml-2 ml|mg|10|1000|Софарма АД|9.76|2|0|1|C||| N02AX02|Tramadol|NP419|TRAMADOL STADA|caps. hard|50|mg|30|1500|Stada Arzenimittel AG|4.28|4|0|1|C||| N02AX02|Tramadol hydrochloride|NP420|TRAMALGIN|caps. hard|50|mg|20|1000|УНИФАРМ АД|2.85|4|0|1|C||| V03AC02|Deferiprone|VH008|Ferriprox|film-coated tabl.|500|mg|100|50000|Apotex Europe B.V., The Netherlands|385.03|4|0|0|C|3|| V03AC01|Deferoxamine|VH009|Desferal|powder for solution for injection|500|mg|10|5000|Novartis Pharma GmbH, Germany|53.58|1|4|0|C|1|| V03AC02|Deferiprone|VH010|Ferriprox|oral solution|100 mg/ml-500 ml|mg|1|50000|Apotex Europe B.V., The Netherlands|340.34|4|0|0|C|3|| V03AF03|Calcium folinate|VH015|Bendafolin|sol. for inj.|10 mg/ml - 100 ml|mg|1|1000|Lyomark Pharma GmbH, Germany|120.18|1|0|0|C|0|1| V03AF03|Calcium folinate|VH016|Bendafolin|sol. for inj.|10 mg/ml - 50 ml|mg|1|500|Lyomark Pharma GmbH, Germany|60.06|1|0|0|C|0|1| V03AF03|Calcium folinate|VH018|Calcium folinate Sandoz|Solution for injection/infusion|10 mg/ml-10 ml|mg|1|100|Sandoz d.d., Словения|12.04|1|0|0|C|0|1| V03AF03|Calcium folinate|VH019|Calcium folinate Sandoz|Solution for injection/infusion|10 mg/ml-5 ml|mg|5|250|Sandoz d.d., Словения|30.06|1|0|0|C|0|1| V03AC03|Deferasirox|VH020|Exjade|Film coated tablet|180|mg|30|5400|Novartis Europharm Limited, Ирландия|699.46|4|0|0|C|3|| V03AF01|Mesna|VH021|UROMITEXAN|SOLUTION FOR INJECTION|100 mg/ml - 4 ml|mg|15|6000|Екофарм Груп АД, България|292.91|1|4|0|C|10||